Clinical Trial Update: EASEGO Study: Doubling of Atorvastatin/Simvastatin or INEGY in Patients With Hypercholesterolemia and Coronary Artery Disease(CAD)(0653A-089) [Phase 4]

View source ↗

Summary

The EASEGO Phase 4 trial evaluated doubling the dose of atorvastatin or simvastatin, or a drug called INEGY, in patients with hypercholesterolemia and coronary …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atherosclerosis
• Coronary Artery Disease
• Hypercholesterolemia

Drugs mentioned

• INEGY
• Lipitor (atorvastatin)
• Zocor (simvastatin)

Snippet

Sponsor: Organon and Co | Conditions: Atherosclerosis | Phase 4 | Status: COMPLETED